RVPH icon

Reviva Pharmaceuticals

14 hedge funds and large institutions have $7.54M invested in Reviva Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TCM
1
Tang Capital Management
California
$3.47M
AC
2
Armistice Capital
New York
$2.05M +$222K +76,878 +12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.43M -$42.3K -14,648 -3%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$217K
ECM
5
EMC Capital Management
Texas
$159K -$59.9K -20,757 -27%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$80K +$4.9K +1,738 +7%
BlackRock
7
BlackRock
New York
$71K -$24.7K -8,634 -26%
Northern Trust
8
Northern Trust
Illinois
$31K
Northwestern Mutual Wealth Management
9
Northwestern Mutual Wealth Management
Wisconsin
$27K +$27K +9,299 New
TRCT
10
Tower Research Capital (TRC)
New York
$11K +$11K +3,826 New
UBS Group
11
UBS Group
Switzerland
$6K +$1.18K +386 +24%
HF
12
HRT Financial
New York
-$54K -13,453 Closed